世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

デジタルPCR市場 - 世界の産業規模、シェア、動向、機会、予測、2018年~2028年Fタイプ別(液滴デジタルPCR、チップベースデジタルPCR、その他)、コンポーネント別(システム、キット・アッセイ、試薬・消耗品)、用途別(腫瘍学、感染症、希少疾患、生殖遺伝学、その他)、エンドユーザー別(学術・研究機関、バイオテクノロジー・製薬企業、病院・クリニック、その他)、地域別、競争状況別


Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028FSegmented by Type (Droplet Digital PCR, Chip Based Digital PCR, Others), By Component (Systems, Kits and Assays, Reagents and Consumables), By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others), By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others), By Region and Competition

世界のデジタルPCR市場は、予測期間2024-2028年に安定したCAGRの成長を目撃すると予測されている。これは、血液癌、肺癌、脳腫瘍のような様々なタイプの癌の有病率の増加と発展途上国の人々の医療費需要の急増に... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2023年7月1日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
113 英語

 

サマリー

世界のデジタルPCR市場は、予測期間2024-2028年に安定したCAGRの成長を目撃すると予測されている。これは、血液癌、肺癌、脳腫瘍のような様々なタイプの癌の有病率の増加と発展途上国の人々の医療費需要の急増に起因している。加えて、世界中で様々な疾患の早期かつ正確な診断に対する需要が高まっていることが、分子診断に対する需要を大幅に増加させ、それによって世界のデジタルPCR市場の成長を支えている。さらに、デジタルPCR技術の進歩と製品発売の増加は、予測期間のデジタルPCR市場の需要を増加させた。PCR技術の進歩を開発するための研究開発活動の需要とデジタルPCRの開発のための企業間の協力協定の増加は、予測期間の世界デジタルPCR市場を押し上げる。世界保健機関(WHO)によると、2021年12月に2億7300万人の症例が診断され、約530万人がCOVID-19が原因で世界的に死亡したと報告されている。
デジタルPCRデバイスの採用増加
世界中で感染症、癌、遺伝性疾患の罹患率が上昇し、新興国ではこれらの疾患の有病率が増加しているにもかかわらず、デジタルPCR技術の採用は都市部では限定的である。しかし、デジタルPCRの利用可能性に関する認知度を高めるために大手企業が行ったイニシアチブ、異なる慢性疾患の診断のための政府機関による投資とイニシアチブの増加、および強力な流通網の確立は、予測期間における市場全体の成長を後押しする。さらに、Digital PCR技術の進歩は、液滴、チップベースPCRなどとともに、今後数年間の市場成長に新たな展望を生み出すと期待されている。その上、特に病原体の遺伝子変異検出のための実験室におけるDigital PCRの採用の増加は、今後数年間の市場成長をサポートすると予想される。さらに、食品微生物学と獣医学における製品アプリケーションの増加は、予測期間においてデジタルPCR市場を推進する。さらに、COVID-19パンデミックの突然の発生と広がり、COVID-19検査におけるさまざまなタイプのPCRデバイスの広範な使用は、デジタルPCR市場を含むさまざまなタイプのPCR市場の成長に新たな展望を生み出している。2022年、米国では合計96,091,120件のCOVID-19症例がカウントされた。
デジタルPCRにおける研究開発活動のための資金増加
COVID19パンデミックのため、医療と研究機関セクターでDigital PCRに対する予想外の需要が増加した。パンデミックはデジタルPCR市場の成長を高める上で重要な役割を果たしている。癌のような感染症の流行も増加し、病気の診断と検出の必要性を説明している。このため、研究開発部門の資金も増加している。様々な目的でのデジタルPCRやチップベースPCRの使用を含む研究開発活動への資金提供の増加は、その使用を増加させ、予測期間中に世界市場拡大の新たな機会を開くと期待されている。
市場セグメンテーション
世界のデジタルPCR市場は、タイプ、コンポーネント、アプリケーション、エンドユーザー、地域別にセグメント化されます。タイプに基づき、市場はDroplet Digital PCR、Chip Based Digital PCR、その他に区分される。コンポーネントに基づくと、市場はシステム、キットとアッセイ、試薬、消耗品に区分される。アプリケーションに基づくと、市場はオンコロジー、感染症、希少疾患、生殖遺伝学、その他に区別できる。エンドユーザーに基づくと、市場は学術・研究機関、バイオテクノロジー・製薬会社、病院・診療所、その他に区分される。地域別では、アジア太平洋、欧州、中東・アフリカ、南米の中で北米が市場を支配している。国別では、米国地域がデジタルPCR市場において世界全体を支配している。Worldometerによると、2022年12月26日現在、米国では約102,236,095件のCOVID-19確定症例が報告されている。これは、医療分野における費用対効果の高いCOVID-19検査技術の増加に起因している。

市場プレーヤー
Bio-Rad Laboratories, Inc.、Fluidigm Corporation、F. Hoffmann-La Roche AG、Merck KGaA、QIAGEN N.V.、Thermo Fisher Scientific Inc.、Genetron Holdings Limited、Naveris, Inc.、SAGA Diagnostics、Precigenome LLCは、世界のデジタルPCR市場で事業を展開する主要企業の一部です。
レポートの範囲
本レポートでは、Digital PCRの世界市場を、業界動向に加えて、以下のカテゴリーに分類しています:
- デジタルPCR市場、タイプ別
o デジタルドロップレットPCR
o チップベースのデジタルPCR
o その他
- デジタルPCR市場、コンポーネント別
o システム
キットとアッセイ
試薬
消耗品
- デジタルPCR市場:アプリケーション別
腫瘍学
o 感染症
o 希少疾患
生殖遺伝学
その他
- デジタルPCR市場、エンドユーザー別
o 学術・研究機関
o バイオテクノロジーおよび製薬会社
o 病院および診療所
その他
- デジタルPCR市場:地域別
北米
 米国
 メキシコ
 カナダ
o ヨーロッパ
 フランス
 ドイツ
 イギリス
 イタリア
 スペイン
o アジア太平洋
 中国
 インド
 韓国
 日本
 オーストラリア

南米
 ブラジル
 アルゼンチン
 コロンビア
中東・アフリカ
 南アフリカ
 サウジアラビア
 UAE
 エジプト
 トルコ

競争環境
企業プロフィール:世界のデジタルPCR市場に存在する主要企業の詳細分析。
利用可能なカスタマイズ:
TechSci Research社は、与えられた市場データをもとに、企業固有のニーズに応じてカスタマイズを提供します。このレポートでは以下のカスタマイズが可能です:

企業情報
- 追加市場プレイヤー(最大5社)の詳細分析とプロファイリング。

ページTOPに戻る


目次

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Digital PCR Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Droplet Digital PCR, Chip Based Digital PCR, Others)
5.2.2. By Component (Systems, Kits and Assays, Reagents and Consumables)
5.2.3. By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)
5.2.4. By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
5.3.1. By Type
5.3.2. By Component
5.3.3. By Application
5.3.4. By End User
5.3.5. By Region
6. North America Digital PCR Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Component
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Digital PCR Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Component
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Mexico Digital PCR Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Component
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Canada Digital PCR Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Component
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Digital PCR Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Component
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Digital PCR Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Component
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Germany Digital PCR Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Component
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Digital PCR Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Component
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Digital PCR Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Component
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Digital PCR Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Component
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Digital PCR Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Component
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Digital PCR Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Component
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Digital PCR Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Component
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. South Korea Digital PCR Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Component
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Japan Digital PCR Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Component
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Digital PCR Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Component
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Digital PCR Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Component
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Digital PCR Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Component
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Digital PCR Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Component
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Digital PCR Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Component
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Digital PCR Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Component
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Digital PCR Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Component
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Digital PCR Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Component
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Digital PCR Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Component
10.3.3.2.3. By Application
10.3.3.2.4. By End User
10.3.4. Egypt Digital PCR Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Component
10.3.4.2.3. By Application
10.3.4.2.4. By End User
10.3.5. Turkey Digital PCR Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Type
10.3.5.2.2. By Component
10.3.5.2.3. By Application
10.3.5.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (As reported)
13.5. Recent Developments
13.6. SWOT Analysis
13.6.1. Bio-Rad Laboratories, Inc.
13.6.2. Fluidigm Corporation
13.6.3. F. Hoffmann-La Roche AG
13.6.4. Merck KGaA
13.6.5. QIAGEN N.V.
13.6.6. Thermo Fisher Scientific Inc.
13.6.7. Genetron Holdings Limited
13.6.8. Naveris, Inc.
13.6.9. SAGA Diagnostics
13.6.10. Precigenome LLC
14. Strategic Recommendations

 

ページTOPに戻る


 

Summary

Global Digital PCR Market is anticipated to witness a growth of steady CAGR in the forecast period 2024-2028. This can be ascribed to the increasing prevalence of various types of cancer like blood cancer, lung cancer, and brain tumor and the surge in demand for healthcare expenditure of people in developing countries. Besides, the growing demand for early and accurate diagnosis of various diseases across the globe has significantly increased the demand for molecular diagnostics, thereby supporting the growth of the global digital PCR market. Additionally, advancements in digital PCR technology and an increasing number of product launches increased the demand for the digital PCR market for the forecast period. The demand in research and development activities for developing advancement in PCR technology and rising collaboration agreements between companies for the development of digital PCR boost the global digital PCR market for the forecast period. According to World Health Organization (WHO), in December 2021, 273 million cases were diagnosed, and approximately 5.3 million deaths have been reported globally due to COVID-19.
Rising Adoption of Digital PCR Devices
Despite the rising incidence of infectious diseases, cancer, and genetic disorders across the globe and the increasing prevalence of these conditions in emerging countries, the adoption of digital PCR techniques is limited in urban regions. However, initiatives taken by leading players to enhance awareness about digital PCR availability, increasing investments and initiatives by government organizations for the diagnosis of different chronic diseases, and the establishment of a strong distribution network will boost the overall market growth in the forecast period. Additionally, advancement in Digital PCR technology, along with droplet, and chip-based PCR, among others, is expected to create new prospects for market growth in the coming years. Besides, the increasing adoption of Digital PCR in laboratories for the detection of genetic mutation detection of pathogens, among others, is expected to support market growth in the coming years. Furthermore, growing product applications in food microbiology and veterinary medicine will propel the digital PCR market in the forecast period. Moreover, the sudden outbreak and spread of the COVID-19 pandemic and the widespread use of different types of PCR devices in COVID-19 testing have created new prospects for the growth of different types of PCR markets, including the digital PCR market. In 2022, a total of 96,091,120 COVID-19 Cases were counted in the United States.
Rising Fund for Research and Development Activities in the Digital PCR
Due to the COVID19 pandemic, an unexpected demand was increased for Digital PCR in the healthcare and research institute sector. The pandemic has played an important role in enhancing the digital PCR market growth. The prevalence of infectious diseases like cancer has also increased, which accounts for the need for the diagnosis and detection of the disease. For this reason, funding in the research and development sector has also increased. Increased funding for R&D activities that include the use of digital PCR and Chip-based PCR for different purposes is expected to increase its use and open up new opportunities for global market expansion during the forecast period.
Market Segmentation
Global Digital PCR market is segmented into type, component, application, end-user, and by region. Based on type, the market can be segmented into Droplet Digital PCR, Chip Based Digital PCR, and Others. Based on components, the market can be segmented into Systems, Kits and Assays, Reagents, and Consumables. Based on application, the market can be differentiated into Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, and Others. Based on end-user, the market can be segmented into Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. In terms of country, the United States region is dominating the overall globe in the digital PCR market. According to Worldometer, as of December 26, 2022, around 102,236,095 confirmed COVID-19 cases have been reported in the United States. This can be ascribed to the increasing cost-effective COVID-19 testing technology in the healthcare sector.

Market Players
Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Genetron Holdings Limited, Naveris, Inc., SAGA Diagnostics, Precigenome LLC are some of the leading players operating in the Global Digital PCR Market.
Report Scope:
In this report, Global Digital PCR market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
• Digital PCR Market, By Type:
o Digital Droplet PCR
o Chip Based on Digital PCR
o Others
• Digital PCR Market, By Component:
o Systems
o Kits and Assays
o Reagents
o Consumables
• Digital PCR Market, By Application:
o Oncology
o Infectious Diseases
o Rare Diseases
o Reproductive Genetics
o Others
• Digital PCR Market, By End User:
o Academic and Research Institutions
o Biotechnology & Pharmaceutical Companies
o Hospitals and Clinics
o Others
• Digital PCR Market, By Region:
o North America
 United States
 Mexico
 Canada
o Europe
 France
 Germany
 United Kingdom
 Italy
 Spain
o Asia Pacific
 China
 India
 South Korea
 Japan
 Australia

o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Egypt
 Turkey

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global Digital PCR Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Digital PCR Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Droplet Digital PCR, Chip Based Digital PCR, Others)
5.2.2. By Component (Systems, Kits and Assays, Reagents and Consumables)
5.2.3. By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others)
5.2.4. By End User (Academic and Research Institutions, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Market Map
5.3.1. By Type
5.3.2. By Component
5.3.3. By Application
5.3.4. By End User
5.3.5. By Region
6. North America Digital PCR Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Component
6.2.3. By Application
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Digital PCR Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Component
6.3.1.2.3. By Application
6.3.1.2.4. By End User
6.3.2. Mexico Digital PCR Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Component
6.3.2.2.3. By Application
6.3.2.2.4. By End User
6.3.3. Canada Digital PCR Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Component
6.3.3.2.3. By Application
6.3.3.2.4. By End User
7. Europe Digital PCR Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Component
7.2.3. By Application
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Digital PCR Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Component
7.3.1.2.3. By Application
7.3.1.2.4. By End User
7.3.2. Germany Digital PCR Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Component
7.3.2.2.3. By Application
7.3.2.2.4. By End User
7.3.3. United Kingdom Digital PCR Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Component
7.3.3.2.3. By Application
7.3.3.2.4. By End User
7.3.4. Italy Digital PCR Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Component
7.3.4.2.3. By Application
7.3.4.2.4. By End User
7.3.5. Spain Digital PCR Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Component
7.3.5.2.3. By Application
7.3.5.2.4. By End User
8. Asia-Pacific Digital PCR Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Component
8.2.3. By Application
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Digital PCR Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Component
8.3.1.2.3. By Application
8.3.1.2.4. By End User
8.3.2. India Digital PCR Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Component
8.3.2.2.3. By Application
8.3.2.2.4. By End User
8.3.3. South Korea Digital PCR Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Component
8.3.3.2.3. By Application
8.3.3.2.4. By End User
8.3.4. Japan Digital PCR Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Component
8.3.4.2.3. By Application
8.3.4.2.4. By End User
8.3.5. Australia Digital PCR Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Component
8.3.5.2.3. By Application
8.3.5.2.4. By End User
9. South America Digital PCR Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Component
9.2.3. By Application
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Digital PCR Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Component
9.3.1.2.3. By Application
9.3.1.2.4. By End User
9.3.2. Argentina Digital PCR Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Component
9.3.2.2.3. By Application
9.3.2.2.4. By End User
9.3.3. Colombia Digital PCR Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Component
9.3.3.2.3. By Application
9.3.3.2.4. By End User
10. Middle East and Africa Digital PCR Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Component
10.2.3. By Application
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Digital PCR Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Component
10.3.1.2.3. By Application
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Digital PCR Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Component
10.3.2.2.3. By Application
10.3.2.2.4. By End User
10.3.3. UAE Digital PCR Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Component
10.3.3.2.3. By Application
10.3.3.2.4. By End User
10.3.4. Egypt Digital PCR Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Type
10.3.4.2.2. By Component
10.3.4.2.3. By Application
10.3.4.2.4. By End User
10.3.5. Turkey Digital PCR Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Type
10.3.5.2.2. By Component
10.3.5.2.3. By Application
10.3.5.2.4. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Competitive Landscape
13.1. Business Overview
13.2. Company Snapshot
13.3. Products & Services
13.4. Financials (As reported)
13.5. Recent Developments
13.6. SWOT Analysis
13.6.1. Bio-Rad Laboratories, Inc.
13.6.2. Fluidigm Corporation
13.6.3. F. Hoffmann-La Roche AG
13.6.4. Merck KGaA
13.6.5. QIAGEN N.V.
13.6.6. Thermo Fisher Scientific Inc.
13.6.7. Genetron Holdings Limited
13.6.8. Naveris, Inc.
13.6.9. SAGA Diagnostics
13.6.10. Precigenome LLC
14. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

TechSci Research社の世界/地域別市場調査分野での最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18 10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る